TRIER PHARM ApS: Financial statements 2015
CVR: 31611083
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 593,750 and a net result of DKK -232,221 compared with DKK -285,259 the year before. That is an increase of 53.4% compared with the year before. The profit margin was -39.1%. Equity in the 2015 report amounted to DKK 238,658. The solvency ratio was 15.5%.
- Revenue
- DKK 593,750
- Gross Profit
- DKK -209,428
- Profit/Loss
- DKK -232,221
- Equity
- DKK 238,658
- Total Assets
- DKK 1,538,057
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 594 t. | -209 t. | -232 t. | 239 t. | - |
| 2014 | 387 t. | -272 t. | -285 t. | 471 t. | - |
| 2013 | 261 t. | -17 t. | -21 t. | 756 t. | - |
| 2012 | 177 t. | 53 t. | 43 t. | 778 t. | - |
Official annual report
How creditworthy is TRIER PHARM ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
TRIER PHARM ApS has published its annual report for 2014. Revenue came to DKK 387,000, and the net result was DKK -285,259.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.